NCT05348070

Brief Summary

Ruptured endometrioma cases were compared with unruptured endometrioma cases.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
181

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2014

Completed
7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 27, 2022

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

7 years

First QC Date

January 25, 2022

Last Update Submit

April 21, 2022

Conditions

Keywords

endometriomaruptureendometriosis

Outcome Measures

Primary Outcomes (4)

  • Pre-interventional Comparison of inflammatory parameters

    Neutrophil/Lymphocyte ratio (NLR), Platelet/Lymphocyte ratio (PLR), Monocyte/Lymphocyte ratio (MLR) were compared between two groups in the preoperative period

    Blood samples were taken from the patients before the surgery

  • Comparison of inflammatory parameters after surgery

    Neutrophil/Lymphocyte ratio (NLR), Platelet/Lymphocyte ratio (PLR), Monocyte/Lymphocyte ratio (MLR) were compared between two groups in the postoperative period

    Blood samples were taken from the patients in the first postoperative day.

  • Pre-interventional Comparison of tumor markers

    Cancer antigens; CA125, CA19-9 and CA 15-3 were compared between two groups in the preoperative period

    Blood samples were taken from the patients before the surgery

  • Comparison of tumor markers after surgery

    Cancer antigens; CA125, CA19-9 and CA 15-3 were compared between two groups in the postoperative period

    Blood samples were taken from the patients after the surgery up to 24 weeks

Secondary Outcomes (2)

  • Sexual activity

    Before surgery

  • Infertility

    Before surgery

Study Arms (2)

Operated Non-Ruptured Endometrioma Group

It consists of patients who were found to have endometrioma in their clinical follow-ups and decided to operate as a result of the evaluations. The patients were operated under elective conditions.

Procedure: Laparoscopy/Laparotomy

Operated Ruptured Endometrioma Group

Rupture of endometrioma, which is a rare gynecological emergency. This group consists of endometrioma patients requiring urgent/subacute operation such as acute abdominal pain, hemodynamic instability, intra-abdominal bleeding. The patients were operated after completing the necessary preparations

Procedure: Laparoscopy/Laparotomy

Interventions

All patients included in the study were operated patients.

Operated Non-Ruptured Endometrioma GroupOperated Ruptured Endometrioma Group

Eligibility Criteria

Age16 Years - 48 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe research was conducted on female patients.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients who were operated on in Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic, whose histopathological diagnosis was confirmed as endometrioma. All patients were women of reproductive age with a pelvic mass.

You may not qualify if:

  • Patients who were operated with a prediagnosis of endometrioma and whose pathological diagnosis was different
  • Patients with smoking, alcohol, substance abuse
  • Patients receiving pelvic radiotherapy/chemotherapy
  • Patients with suspected or confirmed malignancies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Republic of Turkey Ministry of Health, Health Science University Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic

Ankara, Keçiören, 06050, Turkey (Türkiye)

Location

Related Publications (3)

  • Dai X, Jin C, Hu Y, Zhang Q, Yan X, Zhu F, Lin F. High CA-125 and CA19-9 levels in spontaneous ruptured ovarian endometriomas. Clin Chim Acta. 2015 Oct 23;450:362-5. doi: 10.1016/j.cca.2015.09.019. Epub 2015 Sep 25.

    PMID: 26403090BACKGROUND
  • Huang YH, Liou JD, Hsieh CL, Shiau CS, Lo LM, Chang MY. Long-term follow-up of patients surgically treated for ruptured ovarian endometriotic cysts. Taiwan J Obstet Gynecol. 2011 Sep;50(3):306-11. doi: 10.1016/j.tjog.2010.05.002.

    PMID: 22030044BACKGROUND
  • Tanaka K, Kobayashi Y, Dozono K, Shibuya H, Nishigaya Y, Momomura M, Matsumoto H, Iwashita M. Elevation of plasma D-dimer levels associated with rupture of ovarian endometriotic cysts. Taiwan J Obstet Gynecol. 2015 Jun;54(3):294-6. doi: 10.1016/j.tjog.2014.09.010.

Biospecimen

Retention: SAMPLES WITHOUT DNA

all patients who were operated for endometrioma and had a histopathology report confirming the presence of endometrioma Surgical materials were biospecimens, which had a histopathology report confirming the presence of endometrioma

MeSH Terms

Conditions

EndometriosisRupture

Interventions

LaparoscopyLaparotomy

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

EndoscopyDiagnostic Techniques, SurgicalDiagnostic Techniques and ProceduresDiagnosisMinimally Invasive Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Berna Dilbaz, Prof.

    Etlik Zübeyde Hanım Gynecology Training and Research Hospital Infertility Clinic's Chief

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 25, 2022

First Posted

April 27, 2022

Study Start

January 1, 2014

Primary Completion

December 31, 2020

Study Completion

June 20, 2021

Last Updated

April 27, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations